Unichem Labs gets USFDA nod for generic version of Tenormin tablets
Unichem Labs said Atenolol tablets USP is a generic version of TENORMIN (Atenolol) Tablets, 25 mg, 50 mg, and 100 mg, of Alvogen Malta Operations Ltd.
New Delhi: Drugmaker Unichem Laboratories recently said that the company has received approval from the US Food and Drug Administration (USFDA) for hypertension drug Atenolol tablets USP, 25 mg, 50 mg, and 100 mg.
The product is a generic version of TENORMIN (Atenolol) Tablets, 25 mg, 50 mg, and 100 mg, of Alvogen Malta Operations Ltd.
Atenolol Tablets is indicated for the treatment of hypertension, to lower blood pressure.
Also Read: Unichem Labs wins USFDA nod for pain management drug Tramadol Hydrochloride tablets
The product will be commercialized from Unichem's Ghaziabad plant.
Unichem manufactures and markets pharmaceutical formulations as branded generics as well as generics in several markets across the world. In India, it has skills in product development, process chemistry and manufacturing complex API as well as dosage forms.
Also Read: Unichem Labs receives US regulatory nod for a generic version of Buspar tablets
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd